U.S. authorizes Merck pill to fight COVID-19

December 23rd, 20210 WASHINGTON D.C. — Just one day after authorizing Pfizer's Paxlovid pill for at-home use, health regulators have authorized a second pill to combat COVID-19. The Food and Drug Administration (FDA) has authorized Merck’s molnupiravir, although Pfizer’s Paxlovid is likely to become the first-choice treatment due to having milder...

New drug approved by FDA to treat pancreatic cancer patients

January 6th, 20201 KENILWORTH, NJ — A new drug, Lynparza (olaparib) has been approved for pancreatic cancer patients in the United States whose disease has not progressed on at least 16 weeks of a 1st-line platinum-based chemotherapy regimen, a report from Fox 2 Detroit said. The drug, which was originally created for ovarian cancer sufferers, was...